• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本女性患脑腱黄瘤病:新型 CP 基因突变、临床表现及遗传和分子发病机制分析

Aceruloplasminemia in a Japanese woman with a novel mutation of CP gene: clinical presentations and analysis of genetic and molecular pathogenesis.

机构信息

Department of Neurology, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.

出版信息

J Neurol Sci. 2010 Nov 15;298(1-2):136-9. doi: 10.1016/j.jns.2010.08.019. Epub 2010 Sep 15.

DOI:10.1016/j.jns.2010.08.019
PMID:20828764
Abstract

We report a Japanese woman diagnosed as aceruloplasminemia showing characteristic symptoms. Mutational analysis of CP gene revealed a novel homozygous mutation in exon 18, resulting in prematurely truncated W1017X protein. In vitro study showed that W1017X mutant ceruloplasmin was deficient in endoplasmic reticulum to Golgi trafficking and was not secreted to medium. It has been reported that the presence of both the G (FLI/LI) GP domain and the 881th cysteine residue was sufficient for secretion. Thus, our report on this novel mutant indicates the previously unreported importance of carboxy-terminus residues in the secretion pathway.

摘要

我们报告了一位被诊断为铜蓝蛋白血症的日本女性,其表现出典型的症状。CP 基因突变分析显示第 18 外显子存在新型纯合突变,导致 W1017X 蛋白过早截断。体外研究表明,W1017X 突变铜蓝蛋白在内质网到高尔基体的运输过程中存在缺陷,不能分泌到培养基中。据报道,GP 结构域和第 881 位半胱氨酸残基的存在足以促进分泌。因此,我们对这种新型突变体的报告表明,羧基末端残基在分泌途径中具有以前未报道的重要性。

相似文献

1
Aceruloplasminemia in a Japanese woman with a novel mutation of CP gene: clinical presentations and analysis of genetic and molecular pathogenesis.日本女性患脑腱黄瘤病:新型 CP 基因突变、临床表现及遗传和分子发病机制分析
J Neurol Sci. 2010 Nov 15;298(1-2):136-9. doi: 10.1016/j.jns.2010.08.019. Epub 2010 Sep 15.
2
Novel mutation in the ceruloplasmin gene causing a cognitive and movement disorder with diabetes mellitus.
Mov Disord. 2006 Dec;21(12):2217-20. doi: 10.1002/mds.21121.
3
A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans.铜蓝蛋白基因突变与人类全身性含铁血黄素沉着症相关。
Nat Genet. 1995 Mar;9(3):267-72. doi: 10.1038/ng0395-267.
4
Hepatic iron overload associated with a decreased serum ceruloplasmin level in a novel clinical type of aceruloplasminemia.一种新型无铜蓝蛋白血症临床类型中,肝铁过载与血清铜蓝蛋白水平降低相关。
Gastroenterology. 2006 Jul;131(1):240-5. doi: 10.1053/j.gastro.2006.04.017.
5
Cys-881 is essential for the trafficking and secretion of truncated mutant ceruloplasmin in aceruloplasminemia.半胱氨酸-881对于无铜蓝蛋白血症中截短型突变铜蓝蛋白的运输和分泌至关重要。
J Hepatol. 2007 Dec;47(6):844-50. doi: 10.1016/j.jhep.2007.05.013. Epub 2007 Jun 18.
6
Identification and in silico characterization of a novel compound heterozygosity associated with hereditary aceruloplasminemia.与遗传性无铜蓝蛋白血症相关的一种新型复合杂合性的鉴定及计算机模拟特征分析
Scand J Gastroenterol. 2007 Sep;42(9):1088-94. doi: 10.1080/00365520701278810.
7
Aceruloplasminemia: a novel mutation in a family with marked phenotypic variability.无铜蓝蛋白血症:一个具有显著表型变异性的家族中的新突变。
Mov Disord. 2008 Apr 15;23(5):751-5. doi: 10.1002/mds.21938.
8
A nonsense mutation of the ceruloplasmin gene in hereditary ceruloplasmin deficiency with diabetes mellitus.遗传性铜蓝蛋白缺乏症合并糖尿病中铜蓝蛋白基因的无义突变。
Biochem Biophys Res Commun. 1995 Dec 5;217(1):89-95. doi: 10.1006/bbrc.1995.2749.
9
A novel splicing mutation in the ceruloplasmin gene responsible for hereditary ceruloplasmin deficiency with hemosiderosis.一种导致遗传性铜蓝蛋白缺乏伴血色素沉着症的铜蓝蛋白基因新剪接突变。
J Neurol Sci. 1998;156(1):30-4. doi: 10.1016/s0022-510x(98)00015-x.
10
[A case of aceruloplasminemia presenting as cerebellar ataxia with homozygous mutation nt2602 delG].1例以小脑性共济失调为表现、存在纯合子nt2602 delG突变的无铜蓝蛋白血症病例
No To Shinkei. 2004 Oct;56(10):885-9.

引用本文的文献

1
A novel ceruloplasmin mutation identified in a Chinese patient and clinical spectrum of aceruloplasminemia patients.在中国患者中发现的一种新型铜蓝蛋白突变体及铜蓝蛋白血症患者的临床谱。
Metab Brain Dis. 2021 Dec;36(8):2273-2281. doi: 10.1007/s11011-021-00799-0. Epub 2021 Aug 4.
2
Emerging Disease-Modifying Therapies in Neurodegeneration With Brain Iron Accumulation (NBIA) Disorders.脑铁沉积神经退行性疾病(NBIA)中的新兴疾病修饰疗法。
Front Neurol. 2021 Apr 15;12:629414. doi: 10.3389/fneur.2021.629414. eCollection 2021.
3
Effects of iron chelation therapy on the clinical course of aceruloplasminemia: an analysis of aggregated case reports.
螯合疗法对铜蓝蛋白血症临床病程的影响:聚合病例报告分析。
Orphanet J Rare Dis. 2020 Apr 25;15(1):105. doi: 10.1186/s13023-020-01385-w.
4
Deferasirox Might Be Effective for Microcytic Anemia and Neurological Symptoms Associated with Aceruloplasminemia: A Case Report and Review of the Literature.去铁胺可能对与血浆铜蓝蛋白缺乏症相关的小细胞贫血和神经症状有效:一例报告及文献综述
Intern Med. 2020 Jul 15;59(14):1755-1761. doi: 10.2169/internalmedicine.4178-19. Epub 2020 Apr 2.
5
Aceruloplasminemia: Waiting for an Efficient Therapy.无铜蓝蛋白血症:等待有效治疗方法
Front Neurosci. 2018 Dec 4;12:903. doi: 10.3389/fnins.2018.00903. eCollection 2018.
6
Aceruloplasminemia with Abnormal Compound Heterozygous Mutations Developed Neurological Dysfunction during Phlebotomy Therapy.伴有异常复合杂合突变的血浆铜蓝蛋白缺乏症在放血疗法期间出现神经功能障碍。
Intern Med. 2018 Sep 15;57(18):2713-2718. doi: 10.2169/internalmedicine.9855-17. Epub 2018 Apr 27.
7
Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities.脑铁稳态:从分子机制到临床意义和治疗机会。
Antioxid Redox Signal. 2014 Mar 10;20(8):1324-63. doi: 10.1089/ars.2012.4931. Epub 2013 Aug 15.